[144] Pacira BioSciences, Inc. SEC Filing
Rhea-AI Filing Summary
The issuer submitted a Form 144 notice for the proposed sale of 1,500 shares of Common Stock by Fidelity Brokerage Services LLC, dated 04/22/2026, arising from an option granted on 11/04/2024. The excerpt shows shares outstanding of 40,489,894 as of 04/22/2026. The filing also discloses recent sales by Shawn Cross of 7,714 and 2,845 shares on 04/20/2026 and 04/21/2026, respectively.
Positive
- None.
Negative
- None.
Insights
Form 144 records a proposed sale of restricted/affiliate shares under an option.
The filing lists a proposed disposition of 1,500 shares by Fidelity Brokerage Services LLC tied to an option granted 11/04/2024. Form 144s are notice filings required for certain affiliate sales under Rule 144; they do not themselves effect a sale.
Cash‑flow treatment is stated as Cash and the filing lists shares outstanding of 40,489,894 as of 04/22/2026, providing a size context. Subsequent trade execution and settlement details are not included in the excerpt.
Small proposed block relative to the outstanding float; recent insider disposals are also reported.
The proposed 1,500‑share sale represents a small fraction of the disclosed 40,489,894 shares outstanding as of 04/22/2026. The excerpt also records two recent sales by Shawn Cross totaling 10,559 shares with aggregate proceeds shown.
Execution method is listed as Cash; the timing and whether sales will be block trades or market transactions are not specified in the excerpt.